MMC/VICC Partnership : Planning & Evaluation
Program Steering Committee
External evaluation will be by the Program Steering Committee. The membership of this committee in addition to the Co-Principal Investigators and Dr. Sanya Springfield of NCI/ORMH is as follows:
Bernard Levin, M.D.
Professor of Medicine, University of Texas
M.D. Anderson Cancer Center
Franklyn G. Prendergast, M.D., Ph.D.
Professor of Biochemistry and Molecular Biology and Professor of Pharmacology, Mayo Medical School
Director, Mayo Clinic Cancer Center
James Sherley, M.D., Ph.D.
Assistant Professor of Bioengineering and Environmental Health, MIT
Edith Mitchell, M.D.
Professor of Medicine, Thomas Jefferson University
Michael Andrykowski, Ph.D.
Professor of Behavioral Science, University of Kentucky
The Program Steering Committee will meet annually to provide unbiased, rigorous, expert evaluation of progress of the Comprehensive MMC/VICC Partnership. At a minimum, meetings will consist of formal presentations of all aspects of the Partnership activities. We anticipate that members of this committee will meet with faculty and trainees involved in the partnership. The Committee will provide recommendations for improvement based on the objectives and priorities of the implementation plan of the partnership and insights and advice for taking advantage of new objectives and initiatives as the emerge during the course of the grant period. The first PSC meeting is scheduled for March 6, 2002 in Nashville.
